Search Results - "Wan, Andrea"

Refine Results
  1. 1

    FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival by Puthanveetil, Prasanth, Wan, Andrea, Rodrigues, Brian

    Published in Cardiovascular research (01-03-2013)
    “…Diabetic cardiomyopathy is a term used to describe cardiac muscle damage-induced heart failure. Multiple structural and biochemical reasons have been suggested…”
    Get full text
    Journal Article
  2. 2

    Cardiomyocyte-endothelial cell control of lipoprotein lipase by Chiu, Amy Pei-Ling, Wan, Andrea, Rodrigues, Brian

    Published in Biochimica et biophysica acta (01-10-2016)
    “…In people with diabetes, inadequate pharmaceutical management predisposes the patient to heart failure, which is the leading cause of diabetes related death…”
    Get full text
    Journal Article
  3. 3

    Infolding of covered stents used for aortic coarctation: Report of two cases by Wan, Andrea W., Lee, Kyong‐Jin, Benson, Lee N.

    “…Covered stents have been used for the treatment of aortic coarctation to protect the arterial wall during dilation. Early results have shown them to be safe…”
    Get full text
    Journal Article
  4. 4

    The Function of Heparanase in Diabetes and its Complications by Wang, Fang, PhD, Wan, Andrea, BScP, Rodrigues, Brian, PhD

    Published in Canadian journal of diabetes (01-10-2013)
    “…Abstract Heparan sulfate proteoglycans are ubiquitous glycoproteins that contain several heparan sulfate polysaccharide side chains attached to a core protein…”
    Get full text
    Journal Article
  5. 5

    Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy by Wan, Andrea, Rodrigues, Brian

    Published in Cardiovascular research (01-08-2016)
    “…The incidence of diabetes is increasing globally, with cardiovascular disease accounting for a substantial number of diabetes-related deaths. Although…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Neonatal Interventions for Left-Sided Obstructive Lesions by Wan, Andrea, MD, FRCPC, Benson, Lee, MD, FRCPC, FSCAI

    Published in Interventional cardiology clinics (2013)
    “…Percutaneous neonatal cardiac interventions are effective in management strategies. Aortic valve dilation has become a first line therapy with excellent…”
    Get full text
    Journal Article
  8. 8

    Complex Interventions in the Adult with Congenital Heart Disease: Percutaneous Solutions for Venous Baffles, Coronary Artery Fistulas, and Ruptured Sinus of Valsalva Aneurysms by Singh, Harsimran S, Nagy, Christian, Wan, Andrea W, Osten, Mark D, Benson, Lee N, Horlick, Eric M

    Published in Interventional cardiology clinics (01-01-2013)
    “…We describe 3 distinct ACHD lesions amenable to percutaneous repair: (1) venous baffle obstruction in transposition of the great arteries, (2) coronary artery…”
    Get full text
    Journal Article
  9. 9

    Palliative Care?! But This Child’s Not Dying: The Burgeoning Partnership Between Pediatric Cardiology and Palliative Care by Wan, Andrea, Weingarten, Kevin, Rapoport, Adam

    Published in Canadian journal of cardiology (01-07-2020)
    “…The field of pediatric cardiology has witnessed major changes over the past few decades that have considerably altered patient outcomes, including decreasing…”
    Get full text
    Journal Article
  10. 10

    Complex Interventions in the Adult with Congenital Heart Disease by Singh, Harsimran S., MD, MSc, Nagy, Christian, MD, Wan, Andrea W., MD, Osten, Mark D., MD, Benson, Lee N., MD, Horlick, Eric M., MD, CM, FRCPC

    Published in Interventional cardiology clinics (2013)
    “…We describe 3 distinct ACHD lesions amenable to percutaneous repair: (1) venous baffle obstruction in transposition of the great arteries, (2) coronary artery…”
    Get full text
    Journal Article
  11. 11

    Valproic Acid–Associated Hyperammonemia: A Systematic Review by Wong, Yiu-Ching Jennifer, Fan, Julia, Wan, Andrea, Mihic, Tamara, Gnyra, Michelle

    Published in Journal of clinical psychopharmacology (01-05-2023)
    “…Hyperammonemia is an adverse effect that poses clinical uncertainty around valproic acid (VPA) use. The prevalence of symptomatic and asymptomatic…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Lipoprotein lipase and angiopoietin-like 4 - Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease by Puthanveetil, Prasanth, Wan, Andrea, Rodrigues, Brian

    “…Cardiac diseases have been extensively studied following diabetes and altered metabolism has been implicated in its initiation. In this context, there is a…”
    Get full text
    Journal Article
  14. 14

    Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1 by Puthanveetil, Prasanth, Zhang, Dahai, Wang, Ying, Wang, Fang, Wan, Andrea, Abrahani, Ashraf, Rodrigues, Brian

    “…Abstract Cardiomyocyte cell death is a major contributing factor for diabetic cardiomyopathy, and multiple mechanisms have been proposed for its development…”
    Get full text
    Journal Article
  15. 15

    Loss of VEGFB and its signaling in the diabetic heart is associated with increased cell death signaling by Lal, Nathaniel, Chiu, Amy Pei-Ling, Wang, Fulong, Zhang, Dahai, Jia, Jocelyn, Wan, Andrea, Vlodavsky, Israel, Hussein, Bahira, Rodrigues, Brian

    “…Vascular endothelial growth factor B (VEGFB) is highly expressed in metabolically active tissues, such as the heart and skeletal muscle, suggesting a function…”
    Get more information
    Journal Article
  16. 16

    Human Defensin 5 Disulfide Array Mutants: Disulfide Bond Deletion Attenuates Antibacterial Activity against Staphylococcus aureus by Wanniarachchi, Yoshitha A, Kaczmarek, Piotr, Wan, Andrea, Nolan, Elizabeth M

    Published in Biochemistry (Easton) (20-09-2011)
    “…Human α-defensin 5 (HD5, HD5ox to specify the oxidized and disulfide linked form) is a 32-residue cysteine-rich host-defense peptide, expressed and released by…”
    Get full text
    Journal Article
  17. 17

    Abstract 13158: Improving Clinical Outcomes by Implementing a Multi-Disciplinary Pulmonary Vein Stenosis Team by Vanderlaan, Rachel D, Dragulescu, Andreea, Tran, Crystal, Fan, Steve, Wan, Andrea, Yoo, Shi Joon D, Seed, Mike, Grosse-Wortmann, Lars, Grasemann, Harmut, Honjo, Osami, Barron, David, Russell, Jennifer L, Caldarone, Christopher

    Published in Circulation (New York, N.Y.) (16-11-2021)
    “…IntroductionPulmonary vein stenosis (PVS) is a rare disease that is associated with high mortality. In 2015, we instituted a multidisciplinary PVS team and…”
    Get full text
    Journal Article
  18. 18

    Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen During Diabetes Mellitus by Chiu, Amy Pei-Ling, Wan, Andrea, Lal, Nathaniel, Zhang, Dahai, Wang, Fulong, Vlodavsky, Israel, Hussein, Bahira, Rodrigues, Brian

    “…OBJECTIVE—Lipoprotein lipase (LPL)–mediated triglyceride hydrolysis is the major source of fatty acid for cardiac energy. LPL, synthesized in cardiomyocytes,…”
    Get full text
    Journal Article
  19. 19

    Dual effects of hyperglycemia on endothelial cells and cardiomyocytes to enhance coronary LPL activity by Chiu, Amy Pei-Ling, Bierende, Denise, Lal, Nathaniel, Wang, Fulong, Wan, Andrea, Vlodavsky, Israel, Hussein, Bahira, Rodrigues, Brian

    “…In the diabetic heart, there is excessive dependence on fatty acid (FA) utilization to generate ATP. Lipoprotein lipase (LPL)-mediated hydrolysis of…”
    Get more information
    Journal Article
  20. 20

    High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature by Wang, Fulong, Jia, Jocelyn, Lal, Nathaniel, Zhang, Dahai, Chiu, Amy Pei-Ling, Wan, Andrea, Vlodavsky, Israel, Hussein, Bahira, Rodrigues, Brian

    Published in Cardiovascular research (01-12-2016)
    “…The secretion of enzymatically active heparanase (Hep ) has been implicated as an essential metabolic adaptation in the heart following diabetes. However, the…”
    Get full text
    Journal Article